METHODS	The primary comparison was noninferiority of maximum platelet aggregation ( MPA ) comparing the median for prasugrel 5 mg in VE versus the 75th percentile for prasugrel 10 mg in NE , using a pre-specified 1-sided 97.5 % confidence interval for the difference < 15 % .\